Emily Shaw
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 2
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 3
- Co-authors
- Yuanqin Zhang (1 shared paper)Fusheng Si (1 shared paper)David M. Bagley (1 shared paper)Feiya Ma (1 shared paper)Deric Topp (1 shared paper)Edward Bernstein (1 shared paper)Judith Bernstein (1 shared paper)Xia Liu (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Drug Discovery Today (2 papers)Journal of Clinical Pathology (2 papers)British Journal of Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Emily Shaw
26 papers receiving 381 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 90
- Oncology 134
- Pathology and Forensic Medicine 59
- Immunology 68
- Genetics 34
Countries citing papers authored by Emily Shaw
This map shows the geographic impact of Emily Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Shaw more than expected).
Fields of papers citing papers by Emily Shaw
This network shows the impact of papers produced by Emily Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Shaw. The network helps show where Emily Shaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 64 | |
| 2 | 2023 | 54 | |
| 3 | 2009 | 54 | |
| 4 | 2014 | 49 | |
| 5 | 2004 | 29 | |
| 6 | 2012 | 26 | |
| 7 | 2014 | 22 | |
| 8 | 2019 | 22 | |
| 9 | 2021 | 17 | |
| 10 | 2016 | 15 | |
| 11 | 2015 | 4 | |
| 12 | 2024 | 4 | |
| 13 | Self management for chronic disease. An introduction. | 2001 | 4 |
| 14 | 2017 | 4 | |
| 15 | 2012 | 3 | |
| 16 | 2011 | 3 | |
| 17 | What's new in smoking cessation: Zyban. | 1999 | 3 |
| 18 | 2020 | 2 | |
| 19 | 2012 | 2 | |
| 20 | 2022 | 2 |
About Emily Shaw
Emily Shaw is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 27 papers that have together received 390 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Genetic factors in colorectal cancer (2 papers), Primary Care and Health Outcomes (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Cancer Research (90 citations), Oncology (134 citations), Pathology and Forensic Medicine (59 citations), Immunology (68 citations) and Genetics (34 citations). Emily Shaw has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Yuanqin Zhang, Fusheng Si, David M. Bagley, Feiya Ma, Deric Topp, Edward Bernstein, Judith Bernstein, Xia Liu, Guangyong Peng and Gareth J. Thomas. Their work appears in journals such as Journal of Clinical Oncology, Drug Discovery Today, Journal of Clinical Pathology, British Journal of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.